HomeRVPH • NASDAQ
add
Reviva Pharmaceuticals Holdings Inc
Previous close
$1.87
Day range
$1.85 - $2.12
Year range
$0.60 - $4.82
Market cap
65.01M USD
Avg Volume
4.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.46M | -26.82% |
Net income | -8.37M | 26.27% |
Net profit margin | — | — |
Earnings per share | -0.25 | 43.18% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.56M | 11.80% |
Total assets | 7.63M | 41.63% |
Total liabilities | 17.61M | 26.64% |
Total equity | -9.98M | — |
Shares outstanding | 33.44M | — |
Price to book | -6.23 | — |
Return on assets | -269.81% | — |
Return on capital | 268.94% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -8.37M | 26.27% |
Cash from operations | -4.24M | 31.36% |
Cash from investing | — | — |
Cash from financing | 3.62M | — |
Net change in cash | -619.36K | 89.98% |
Free cash flow | -1.43M | 48.70% |
About
Founded
2018
Headquarters
Website
Employees
15
